BARDA Awards $20.5M To Sabin Vaccine Institute To Research Marburg, Sudan Ebolavirus Vaccines
Homeland Preparedness News: BARDA awards more than $20M for Marburg, Sudan ebolavirus vaccines
“The Biomedical Advanced Research and Development Authority (BARDA) awarded the Albert B. Sabin Vaccine Institute Inc. of Washington, D.C., with about $20.5 million to develop vaccines against Marburg virus and Sudan ebolavirus infections. Both diseases are caused by the same family of viruses as the Ebola virus, which is currently affecting communities in the Democratic Republic of the Congo. … With the award, the Sabin Vaccine Institute will conduct studies and complete manufacturing activities to advance the development of both vaccines…” (Kovaleski, 10/3).